| # |
Company Name
|
Industry Name
|
Latest Price (Rs.)
|
Price Change
Rs (%) |
Market Cap
|
Net Sales
(Rs. Cr.) |
Latest EPS
(Rs.) |
Net Profit
Margin % |
Latest
P/E |
Latest
P/BV |
|---|---|---|---|---|---|---|---|---|---|---|
| Dr. Reddys Labs. | Pharmaceuticals& Drugs | 1,245.3 |
10.65 (0.86%) |
Mid Cap | 33,700 | 50.3 | 11.44 | 24.6 | 2.7 | |
| Zydus Lifesciences | Pharmaceuticals& Drugs | 1,145.9 |
14.8 (1.31%) |
Mid Cap | 27,148 | 50.5 | 16.54 | 22.4 | 4.3 | |
| Lupin | Pharmaceuticals& Drugs | 2,493.8 |
-3.95 (-0.16%) |
Mid Cap | 22,708 | 116.6 | 14.55 | 21.4 | 5.1 | |
| Glenmark Pharma. | Pharmaceuticals& Drugs | 2,311.9 |
10.5 (0.46%) |
Mid Cap | 13,322 | 48.3 | 9.67 | 47.7 | 6.2 | |
| Aurobindo Pharma | Pharmaceuticals& Drugs | 1,568.4 |
18.75 (1.21%) |
Mid Cap | 10,933 | 42 | 15.17 | 36.9 | 3.9 | |
| Mankind Pharma | Pharmaceuticals& Drugs | 2,525 |
15.75 (0.63%) |
Mid Cap | 10,421 | 49.3 | 19.97 | 50.9 | 6.3 | |
| Alkem Laboratories | Pharmaceuticals& Drugs | 5,651.3 |
76.4 (1.37%) |
Mid Cap | 8,813 | 182.8 | 23.18 | 30.5 | 4.8 | |
| Max Healthcare Inst. | Hospital &HealthcareServices | 1,105 |
-3.15 (-0.28%) |
Mid Cap | 8,373 | 14.8 | 17.65 | 74.8 | 10.2 | |
| Laurus Labs | Pharmaceuticals& Drugs | 1,566.8 |
9.2 (0.59%) |
Mid Cap | 6,813 | 16.5 | 12.82 | 94.7 | 16 | |
| Ipca Laboratories | Pharmaceuticals& Drugs | 1,846.1 |
22.05 (1.21%) |
Mid Cap | 6,635 | 44.6 | 12.45 | 40.9 | 5.8 | |
| Abbott India | Pharmaceuticals& Drugs | 27,323.7 |
-60.6 (-0.22%) |
Mid Cap | 6,409 | 730.4 | 22.1 | 37.5 | 12.2 | |
| Narayana Hrudayalay. | Hospital &HealthcareServices | 2,018.2 |
-17.85 (-0.88%) |
Mid Cap | 5,483 | 39.4 | 14.35 | 51.7 | 9.2 | |
| Ajanta Pharma | Pharmaceuticals& Drugs | 3,380 |
-43.65 (-1.27%) |
Mid Cap | 5,453 | 84.5 | 19.33 | 40.5 | 9.5 | |
| Aster DM Quality | Hospital &HealthcareServices | 818.2 |
3.4 (0.42%) |
Mid Cap | 4,138 | 7.5 | 8.01 | 108.8 | 9.2 | |
| Lenskart Solutions | MedicalEquipment/Supplies/Accessories | 539 |
0.45 (0.08%) |
Mid Cap | 4,039 | 2.7 | 4.65 | 196.8 | 10.3 | |
| Glaxosmithkline Phar | Pharmaceuticals& Drugs | 2,481.3 |
64 (2.65%) |
Mid Cap | 3,822 | 61.2 | 25.36 | 39.5 | 17.9 | |
| Biocon | Pharmaceuticals& Drugs | 444.3 |
33.75 (8.22%) |
Mid Cap | 2,243 | 0.2 | 8.04 | 1,798.6 | 2.5 | |
| Anthem Biosciences | Pharmaceuticals& Drugs | 750.3 |
3 (0.4%) |
Mid Cap | 2,089 | 11.9 | 30.95 | 62.8 | 13.4 | |
| Fortis Healthcare | Hospital &HealthcareServices | 962.7 |
-1.75 (-0.18%) |
Mid Cap | 1,446 | 3.1 | 9.99 | 316.1 | 7.9 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: